Deciphera Pharmaceuticals, Inc. Pre-Tax Income
Deciphera Pharmaceuticals, Inc. reported Pre-Tax Income of -$194.51 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$194.51M.
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$178.21M.
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2021 was -$299.96M.
- Deciphera Pharmaceuticals, Inc. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2020 was -$266.49M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|
| 2023-12-31 | -$194.51M 10-K · filed 2024-02-07 |
| 2022-12-31 | -$178.21M 10-K · filed 2024-02-07 |
| 2021-12-31 | -$299.96M 10-K · filed 2024-02-07 |
| 2020-12-31 | -$266.49M 10-K · filed 2023-02-07 |
| 2019-12-31 | -$192.26M 10-K · filed 2022-02-08 |